Procyon Corp (PCYN) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
1300 S HIGHLAND AVE CLEARWATER, FL 33756 |
| State of Incorp. | CO |
| Fiscal Year End | June 30 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
| 6/30/2024 Q4 | 3/31/2024 Q3 | 12/31/2023 Q2 | 9/30/2023 Q1 | 6/30/2023 Q4 | 3/31/2023 Q3 | 12/31/2022 Q2 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 902 | 839 | 969 | 1,014 | 882 | 886 | |||
| Cash and cash equivalents | 902 | 839 | 969 | 1,014 | 882 | 886 | |||
| Receivables | 482 | 510 | 434 | 494 | 513 | 586 | |||
| Inventory, net of allowances, customer advances and progress billings | 535 | 531 | 544 | 431 | 549 | 552 | |||
| Inventory | 535 | 531 | 544 | 431 | 549 | 552 | |||
| Other undisclosed current assets | 373 | 228 | 216 | 298 | 455 | 257 | |||
| Total current assets: | 2,292 | 2,107 | 2,163 | 2,238 | 2,399 | 2,280 | |||
| Noncurrent Assets | |||||||||
| Inventory, Noncurrent | 266 | 287 | 287 | 331 | 321 | 303 | |||
| Operating lease, right-of-use asset | 386 | 433 | 480 | 527 | 571 | 616 | |||
| Property, plant and equipment | 281 | 301 | 315 | 281 | 146 | 155 | |||
| Intangible assets, net (including goodwill) | 17 | 17 | 17 | 17 | 17 | 17 | |||
| Intangible assets, net (excluding goodwill) | 17 | 17 | 17 | 17 | 17 | 17 | |||
| Deposits noncurrent assets | 5 | 5 | 5 | 9 | 9 | 9 | |||
| Deferred income tax assets | 16 | 171 | 161 | 164 | 155 | ||||
| Total noncurrent assets: | 955 | 1,059 | 1,275 | 1,326 | 1,229 | 1,255 | |||
| TOTAL ASSETS: | 3,247 | 3,166 | 3,438 | 3,564 | 3,628 | 3,535 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 208 | 209 | 172 | 277 | 208 | 131 | |||
| Accounts payable | 208 | 209 | 172 | 208 | 131 | ||||
| Accrued liabilities | 185 | ||||||||
| Other undisclosed accounts payable and accrued liabilities | 93 | ||||||||
| Other undisclosed current liabilities | 582 | 374 | 396 | 349 | 446 | 358 | |||
| Total current liabilities: | 791 | 583 | 568 | 626 | 654 | 489 | |||
| Noncurrent Liabilities | |||||||||
| Liabilities, other than long-term debt | 207 | 231 | 275 | 320 | 364 | 407 | |||
| Deferred income tax liabilities | 21 | ||||||||
| Operating lease, liability | 185 | 231 | 275 | 320 | 364 | 407 | |||
| Total noncurrent liabilities: | 207 | 231 | 275 | 320 | 364 | 407 | |||
| Total liabilities: | 997 | 814 | 844 | 946 | 1,018 | 896 | |||
| Equity | |||||||||
| Equity, attributable to parent, including: | 2,249 | 2,352 | 2,595 | 2,618 | 2,610 | 2,640 | |||
| Common stock | 4,450 | 4,450 | 4,450 | 4,445 | 4,445 | 4,445 | |||
| Additional paid in capital | 41 | 41 | 41 | 36 | 36 | 36 | |||
| Accumulated deficit | (2,369) | (2,266) | (2,023) | (1,989) | (1,997) | (1,968) | |||
| Other undisclosed equity, attributable to parent | 127 | 127 | 127 | 127 | 127 | 127 | |||
| Total equity: | 2,249 | 2,352 | 2,595 | 2,618 | 2,610 | 2,640 | |||
| TOTAL LIABILITIES AND EQUITY: | 3,247 | 3,166 | 3,438 | 3,564 | 3,628 | 3,535 | |||
Income Statement (P&L) ($ in thousands)Annual | Quarterly
| 6/30/2024 Q4 | 3/31/2024 Q3 | 12/31/2023 Q2 | 9/30/2023 Q1 | 6/30/2023 Q4 | 3/31/2023 Q3 | 12/31/2022 Q2 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 1,199 | 1,200 | 1,173 | 1,202 | 1,125 | 1,184 | ||
| Cost of revenue (Cost of Goods and Services Sold) | (261) | (263) | (261) | (265) | (264) | (293) | ||
| Gross profit: | 938 | 937 | 912 | 937 | 861 | 890 | ||
| Operating expenses | (1,020) | (1,038) | (970) | (940) | (913) | (922) | ||
| Operating income (loss): | (82) | (101) | (57) | (3) | (51) | (32) | ||
| Nonoperating income | 16 | 14 | 14 | 14 | 12 | 5 | ||
| Investment income, nonoperating | 9 | 9 | 9 | 9 | 3 | |||
| Income (loss) from continuing operations before income taxes: | (66) | (87) | (43) | 11 | (39) | (27) | ||
| Income tax expense (benefit) | (37) | (155) | 9 | (3) | 9 | 6 | ||
| Net income (loss) attributable to parent: | (103) | (242) | (34) | 7 | (29) | (20) | ||
| Preferred stock dividends and other adjustments | (4) | (4) | (4) | (4) | (4) | (4) | ||
| Net income (loss) available to common stockholders, diluted: | (107) | (247) | (37) | 3 | (34) | (24) | ||
Comprehensive Income ($ in thousands)Annual | Quarterly
| 6/30/2024 Q4 | 3/31/2024 Q3 | 12/31/2023 Q2 | 9/30/2023 Q1 | 6/30/2023 Q4 | 3/31/2023 Q3 | 12/31/2022 Q2 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | (103) | (242) | (34) | 7 | (29) | (20) | ||
| Comprehensive income (loss), net of tax, attributable to parent: | (103) | (242) | (34) | 7 | (29) | (20) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.